Cagri/Reta helps researchers study dual-pathway metabolic effects combining amylin and GLP-1/GIP/glucagon signaling. A cutting-edge combo for weight management and metabolic research.
Product Details
98%+ purity, third-party tested
Certificate of Analysis (COA) included
Fulfilled from the USA
For laboratory research use only (RUO) — not for human consumption